Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Terence Sanger, University of Southern California
ClinicalTrials.gov Identifier:
NCT00473161
First received: May 11, 2007
Last updated: May 21, 2014
Last verified: May 2014
  Purpose

A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.


Condition Intervention Phase
Cerebral Palsy
Weakness
Hypertonia
Device: surface EMG biofeedback
Phase 1
Phase 2

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University of Southern California:

Estimated Enrollment: 20
Study Start Date: May 2007
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Detailed Description:

Children ages newborn to 21 with a diagnosis of arm weakness, hypertonia, or hyperkinesia due to cerebral palsy will be recruited. A muscle that is either over-active or under-active will be selected for each child. The child will be provided with the device to wear for 1 month in order to call attention to the identified muscle. At the beginning and end of the month, reaching will be assessed using three-dimensional kinematic motion capture. The outcome measure will be the speed and curvature of reaching to a target in front of the child.

  Eligibility

Ages Eligible for Study:   1 Month to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Children with movement disorders, cerebral palsy.

Criteria

Inclusion Criteria:

  • weakness, hypertonia, or hyperkinetic disorder affecting one or both arms
  • reduced speed or quality of reaching

Exclusion Criteria:

  • any condition that would increase the risk of participation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00473161

Locations
United States, California
Stanford University
Stanford, California, United States, 94305
Sponsors and Collaborators
University of Southern California
Investigators
Principal Investigator: Terence D Sanger, MD PhD Stanford University
  More Information

No publications provided

Responsible Party: Terence Sanger, Associate Professor, University of Southern California
ClinicalTrials.gov Identifier: NCT00473161     History of Changes
Other Study ID Numbers: EMG biofeedback
Study First Received: May 11, 2007
Last Updated: May 21, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of Southern California:
movement disorders
childhood

Additional relevant MeSH terms:
Cerebral Palsy
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on September 18, 2014